AAPG P/E Ratio
P/E Ratio as of Jun 13, 2025: -42.04
Average-35.57
Median-34.44
Minimum-42.72
Maximum-30.09
-42.04
Past Month-10.82 (34.66%)
The P/E ratio for AAPG is -42.04 as of Jun 13, 2025. This represents a increase of 186.18% compared to its 12-month average P/E ratio of -14.69. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Ascentage Pharma Group International P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Ascentage Pharma Group International’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ascentage Pharma Group International to industry peers.
Ascentage Pharma Group International P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Ascentage Pharma Group International’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ascentage Pharma Group International to industry peers.
AAPG P/E Ratio Insights
See Ascentage Pharma Group International’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in AAPG
Order type
Buy in
Order amount
Est. shares
0 shares
AAPG P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $25.22 | -33.65 |
| May 1, 2025 | $25.15 | -33.56 |
| Apr 1, 2025 | $23.04 | -30.74 |
| Mar 3, 2025 | $18.67 | -27.03 |
| Feb 3, 2025 | $18.20 | -26.35 |
| Jan 27, 2025 | $17.25 | -24.98 |
AAPG End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -42.04 | — |
FAQs About Ascentage Pharma Group International (AAPG) P/E ratio
The latest P/E ratio of AAPG is -42.04, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Ascentage Pharma Group International’s last 12-month average P/E ratio is -14.69, compared to its current P/E ratio of -42.04. This reflects a increase of 186.18%.
Ascentage Pharma Group International’s current P/E ratio of -42.04 is higher than its last 12-month average P/E of -14.69. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Ascentage Pharma Group International’s average P/E ratio over the last 3 years is -4.9. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Ascentage Pharma Group International’s average P/E ratio over the last 5 years is -2.94. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.